Balhara Yatan Pal Singh, Singh Shalini, Kalra Sanjay
Department of Psychiatry, National Drug Dependence Treatment Center, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Institute of Liver and Biliary Sciences (ILBS), New Delhi, India.
Eur Endocrinol. 2020 Apr;16(1):21-24. doi: 10.17925/EE.2020.16.1.21. Epub 2020 Feb 4.
The management of painful diabetic neuropathy poses a tough clinical challenge. Although opioid analgesics are considered as second- or third-line agents in the management of moderate-to-severe neuropathic pain, prescription of opioids for this indication is higher than expected. This narrative review is a recommendation on how to ensure pragmatic use of opioids for those with painful diabetic neuropathy while avoiding complications such as opioid overdose, opioid diversion and the development of opioid-use disorder. Risk mitigation strategies at the level of the clinician include periodic assessment and documentation of clinical details, treatment history and psychosocial status. Using a multimodal approach to pain management, medication counselling, adherence monitoring programmes, evidence-based opioid dosing strategies and empowering patients to make treatment decisions are effective strategies in reducing risk associated with prolonged opioid use. At the organisational and policy level, using prescription drug monitoring programmes, carrying out periodic opioid utilisation reviews and providing training to patients and physicians on safe opioid use are useful, implementable strategies.
疼痛性糖尿病神经病变的管理是一项严峻的临床挑战。尽管阿片类镇痛药在中重度神经病理性疼痛的管理中被视为二线或三线药物,但针对这一适应症开具阿片类药物的处方量高于预期。这篇叙述性综述是关于如何确保对疼痛性糖尿病神经病变患者切实合理使用阿片类药物,同时避免诸如阿片类药物过量、阿片类药物转移以及阿片类药物使用障碍等并发症的建议。临床医生层面的风险缓解策略包括定期评估和记录临床细节、治疗史及社会心理状况。采用多模式疼痛管理方法、药物咨询、依从性监测计划、基于证据的阿片类药物给药策略以及让患者参与治疗决策,都是降低与长期使用阿片类药物相关风险的有效策略。在组织和政策层面,利用处方药监测计划、定期开展阿片类药物使用审查以及为患者和医生提供安全使用阿片类药物的培训,都是有用且可实施的策略。